Next Article in Journal
The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies
Next Article in Special Issue
Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products
Previous Article in Journal
Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy
Previous Article in Special Issue
DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity
Open AccessReview

AIDS Clinical Research in Spain—Large HIV Population, Geniality of Doctors, and Missing Opportunities

1
Infectious Diseases Unit, La Paz University Hospital, 28046 Madrid, Spain
2
UNIR Health Sciences School, 28040 Madrid, Spain
3
Department of Internal Medicine, General University Hospital, 03010 Alicante, Spain
4
Department of Infectious Diseases, University Hospital Crosshouse, Kilmarnock KA2 0BE, UK
*
Author to whom correspondence should be addressed.
Viruses 2018, 10(6), 293; https://doi.org/10.3390/v10060293
Received: 3 May 2018 / Revised: 24 May 2018 / Accepted: 25 May 2018 / Published: 30 May 2018
(This article belongs to the Special Issue Homage to Mark Wainberg)
The first cases of AIDS in Spain were reported in 1982. Since then over 85,000 persons with AIDS have been cumulated, with 60,000 deaths. Current estimates for people living with HIV are of 145,000, of whom 20% are unaware of it. This explains the still high rate of late HIV presenters. Although the HIV epidemic in Spain was originally driven mostly by injection drug users, since the year 2000 men having sex with men (MSM) account for most new incident HIV cases. Currently, MSM represent over 80% of new yearly HIV diagnoses. In the 80s, a subset of young doctors and nurses working at Internal Medicine hospital wards became deeply engaged in attending HIV-infected persons. Before the introduction of antiretrovirals in the earlier 1990s, diagnosis and treatment of opportunistic infections was their major task. A new wave of infectious diseases specialists was born. Following the wide introduction of triple combination therapy in the late 1990s, drug side effects and antiretroviral resistance led to built a core of highly devoted HIV specialists across the country. Since then, HIV medicine has improved and currently is largely conducted by multidisciplinary teams of health care providers working at hospital-based outclinics, where HIV-positive persons are generally seen every six months. Antiretroviral therapy is currently prescribed to roughly 75,000 persons, almost all attended at clinics belonging to the government health public system. Overall, the impact of HIV/AIDS publications by Spanish teams is the third most important in Europe. HIV research in Spain has classically been funded mostly by national and European public agencies along with pharma companies. Chronologically, some of the major contributions of Spanish HIV research are being in the field of tuberculosis, toxoplasmosis, leishmaniasis, HIV variants including HIV-2, drug resistance, pharmacology, antiretroviral drug-related toxicities, coinfection with viral hepatitis, design and participation in clinical trials with antiretrovirals, immunopathogenesis, ageing, and vaccine development. View Full-Text
Keywords: HIV research; HIV prevention; HIV education; antiretroviral therapy; Spain; hepatitis; AIDS history HIV research; HIV prevention; HIV education; antiretroviral therapy; Spain; hepatitis; AIDS history
Show Figures

Figure 1

MDPI and ACS Style

Soriano, V.; Ramos, J.M.; Barreiro, P.; Fernandez-Montero, J.V. AIDS Clinical Research in Spain—Large HIV Population, Geniality of Doctors, and Missing Opportunities. Viruses 2018, 10, 293.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop